RxDoctor Payments Data

Yohani Torres

Physician Assistant · Naples, FLNPI 1942247697

Payments from drug & device makers

$2,901in general payments, 2019–2025

Across 100 payments — averaging $29.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$980
  • AbbVie$268
  • Johnson & Johnson$264
  • Organogenesis Inc.$136
  • Astellas Pharma US Inc$121
  • Endo Pharmaceuticals Inc.$119
  • plus $1K from 24 others

What the payments were for

  • Travel & lodging$56319%
  • Food & beverage$2,33881%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,901 in reported general payments places this provider in the 80th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron105$126,785
MyrbetriqMirabegron32$31,697
Tamsulosin Hcl429$7,094
Silodosin56$5,749
Solifenacin Succinate61$4,473
Testosterone Cypionate71$4,217
Estradiol66$3,616
Testosterone12$3,479
Finasteride256$3,320
Potassium Citrate ErPotassium Citrate22$2,787
Tolterodine Tartrate ErTolterodine Tartrate24$2,361
Methenamine Hippurate21$1,359
Bethanechol Chloride16$1,182
Oxybutynin Chloride ErOxybutynin Chloride45$970
NitrofurantoinNitrofurantoin Macrocrystal17$697

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$72$126,785105 claims
Astellas Pharma US IncMyrbetriq$121$31,69732 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →